ENvue Medical delays quarterly SEC filing

ENvue Medical Inc ( (FEED) ) has released a notification of late filing.

ENvue Medical, Inc. has notified investors that it will delay filing its Form 10-Q (Quarter Report) for the quarter ended March 31, 2026, via a Form 12b-25. The company says the late filing relates specifically to this quarterly report and not to any annual Form 10-K (Yearly Report) or foreign issuer Form 20-F (Yearly Report).

Management cites the need for additional time to prepare, compile and analyze supporting documentation for its disclosures and financial statements as the key reason for the delay. The company emphasizes that filing on time would require unreasonable effort and expense, suggesting workload and process constraints rather than a specific control failure or external audit issue.

ENvue Medical, Inc. expects to submit the delayed Form 10-Q (Quarter Report) within the standard SEC extension period. The company states that it anticipates filing no later than the fifth calendar day after the original due date for the quarterly report.

The company indicates that all other required periodic reports over the past 12 months have been filed. It also states that it does not expect any significant change in results of operations versus the same quarter last year, though investors should remember that such expectations are inherently forward-looking and subject to revision when the actual Form 10-Q (Quarter Report) is filed.

ENvue notes that it is continuing its normal financial review and disclosure processes to bring the Form 10-Q (Quarter Report) to completion within the allowed grace period. The notification is signed on behalf of the company by Chief Executive Officer Doron Besser, M.D., dated May 15, 2026, underscoring executive-level responsibility for timely compliance.

More about ENvue Medical Inc

Average Trading Volume: 2,968,620

Technical Sentiment Signal: Strong Sell

Current Market Cap: $4.18M

See more insights into FEED stock on TipRanks’ Stock Analysis page.